Terms: = Head and neck cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Staging
7 results:
1. Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma.
Andersson BÅ; Lewin F; Lundgren J; Nilsson M; Rutqvist LE; Löfgren S; Laytragoon-Lewin N
J Cancer Res Clin Oncol; 2014 Mar; 140(3):515-9. PubMed ID: 24481866
[TBL] [Abstract] [Full Text] [Related]
2. Skewed distribution of IL-7 receptor-α-expressing effector memory CD8+ T cells with distinct functional characteristics in oral squamous cell carcinoma.
Lee JJ; Yeh CY; Jung CJ; Chen CW; Du MK; Yu HM; Yang CJ; Lin HY; Sun A; Ko JY; Cheng SJ; Chang YL; Chia JS
PLoS One; 2014; 9(1):e85521. PubMed ID: 24465587
[TBL] [Abstract] [Full Text] [Related]
3. Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.
Tímár J; Ladányi A; Forster-Horváth C; Lukits J; Döme B; Remenár E; Godény M; Kásler M; Bencsik B; Répássy G; Szabó G; Velich N; Suba Z; Elo J; Balatoni Z; Pócza K; Zemplén B; Chretien P; Talor E
J Clin Oncol; 2005 May; 23(15):3421-32. PubMed ID: 15908653
[TBL] [Abstract] [Full Text] [Related]
4. A new preoperative immunochemotherapy for the treatment of locally advanced esophageal cancer.
Okuno K; Tanaka A; Yoshikawa H; Shigeoka H; Jinnai H; Lee YS; Hirai N; Matsumura E; Kawai I; Yasutomi M
Hepatogastroenterology; 1998; 45(22):950-3. PubMed ID: 9755987
[TBL] [Abstract] [Full Text] [Related]
5. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
Tartour E; Deneux L; Mosseri V; Jaulerry C; Brunin F; Point D; Validire P; Dubray B; Fridman WH; Rodriguez J
Cancer; 1997 Apr; 79(7):1401-8. PubMed ID: 9083163
[TBL] [Abstract] [Full Text] [Related]
6. Response to and concentration of interleukin-2 in patients with nasopharyngeal carcinoma.
Hsu MM; Hsu LW
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 Aug; 22(3):181-5. PubMed ID: 2605977
[TBL] [Abstract] [Full Text] [Related]
7. Interleukin 2 (IL 2) relationships with the cancer-related immunodeficiency: in vitro response to exogenous IL 2 by PHA-activated and non PHA-activated peripheral blood mononuclear cells from cancer patients.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Diagn Clin Immunol; 1987; 5(2):104-11. PubMed ID: 3497733
[TBL] [Abstract] [Full Text] [Related]
